Doing some back of the envelope calculations and I don't think the potential of the BHA acquisition has been fully priced in
The current conversion rate from being "Shown a video" to "Subscribed" is around 30% according to the presentations and the data been provided so far
Let's assume they hold at 30% moving forward - which is conservative given auto-gen is meant to help conversion
There's 14K customers (11.2K shown a video and 3.8K in production), plus another 36K from BHA in the pipeline
If they converted 30% of them to subscribers, that means another 15.3K of subscribers.
Based on ARPU of $5K as per FY17Q3, that's $76.5M annualised contract value (ACV). Even conservative APRU of $2.5K means it's $38.3M ACV.
The current ACV as Q3 is ~$15M
Even assuming it takes 12 months to convert the entire pipeline, that's nearly 4x the current ACV in 12 months with no further growth
Massive potential here
- Forums
- ASX - By Stock
- BIG
- Autogen Tech
Autogen Tech, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online